Matches in Nanopublications for { ?s ?p ?o <http://rdf.disgenet.org/nanopublications.trig#NP556595.RAtpn92iEfC-AItsLoKj5l_CTyaDCh8lHX_nlwwuJfT1I130_provenance>. }
Showing items 1 to 9 of
9
with 100 items per page.
- source_evidence_literature type ECO_0000212 NP556595.RAtpn92iEfC-AItsLoKj5l_CTyaDCh8lHX_nlwwuJfT1I130_provenance.
- source_evidence_literature label "DisGeNET evidence - LITERATURE" NP556595.RAtpn92iEfC-AItsLoKj5l_CTyaDCh8lHX_nlwwuJfT1I130_provenance.
- source_evidence_literature comment "Gene-disease associations inferred from text-mining the literature." NP556595.RAtpn92iEfC-AItsLoKj5l_CTyaDCh8lHX_nlwwuJfT1I130_provenance.
- NP556595.RAtpn92iEfC-AItsLoKj5l_CTyaDCh8lHX_nlwwuJfT1I130_assertion description "[The p16INK4 family of CDK inhibitors specifically prevent the phosphorylation of the retinoblastoma susceptibility gene product, pRb, by inhibiting the kinase activity of CDK4 and CDK6, thereby keeping pRb in its active form as a growth suppressor.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP556595.RAtpn92iEfC-AItsLoKj5l_CTyaDCh8lHX_nlwwuJfT1I130_provenance.
- NP556595.RAtpn92iEfC-AItsLoKj5l_CTyaDCh8lHX_nlwwuJfT1I130_assertion evidence source_evidence_literature NP556595.RAtpn92iEfC-AItsLoKj5l_CTyaDCh8lHX_nlwwuJfT1I130_provenance.
- NP556595.RAtpn92iEfC-AItsLoKj5l_CTyaDCh8lHX_nlwwuJfT1I130_assertion SIO_000772 8934552 NP556595.RAtpn92iEfC-AItsLoKj5l_CTyaDCh8lHX_nlwwuJfT1I130_provenance.
- NP556595.RAtpn92iEfC-AItsLoKj5l_CTyaDCh8lHX_nlwwuJfT1I130_assertion wasDerivedFrom befree-20140225 NP556595.RAtpn92iEfC-AItsLoKj5l_CTyaDCh8lHX_nlwwuJfT1I130_provenance.
- NP556595.RAtpn92iEfC-AItsLoKj5l_CTyaDCh8lHX_nlwwuJfT1I130_assertion wasGeneratedBy ECO_0000203 NP556595.RAtpn92iEfC-AItsLoKj5l_CTyaDCh8lHX_nlwwuJfT1I130_provenance.
- befree-20140225 importedOn "2014-02-25" NP556595.RAtpn92iEfC-AItsLoKj5l_CTyaDCh8lHX_nlwwuJfT1I130_provenance.